United BioSource (UBC) Acquires Examoto, LLC
July 28, 2022
United BioSource (UBC) has acquired Examoto, LLC, a provider of FDA-mandated REMS compliance platforms and risk-mitigation technology for the pharmaceutical industry. The acquisition expands UBC's REMS capabilities by combining Examoto's technology-driven REMS platform with UBC's scientific, safety, and commercialization services; terms were not disclosed.
- Buyers
- United BioSource LLC (UBC)
- Targets
- Examoto, LLC
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
United BioSource (UBC) Acquires Evidinno Outcomes Research
January 5, 2026
Healthcare Services
United BioSource LLC (UBC) acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and health economics/HEOR. The acquisition will expand UBC’s evidence generation and late-stage/post-approval capabilities, with Evidinno operating as a wholly owned subsidiary.
-
iuvo BioScience Acquires Promedica International
January 18, 2024
Healthcare Services
iuvo BioScience, a Rochester-based specialty preclinical and clinical services provider backed by Ampersand Capital Partners, has acquired Promedica International, an ophthalmology-focused clinical CRO headquartered in Costa Mesa, California. The deal combines iuvo's laboratory and consulting capabilities with Promedica's ophthalmic clinical trial expertise to create an integrated end-to-end ophthalmology clinical research offering.
-
Symeres Acquires Exemplify BioPharma
October 25, 2022
Pharmaceuticals
Symeres, a Netherlands-headquartered transatlantic CRO/CDMO majority‑owned by Keensight Capital, has acquired Exemplify BioPharma, a Cranbury, New Jersey-based CMC-focused CRO. The deal strengthens Symeres' capabilities in process and analytical chemistry and formulation development and further expands its strategic foothold in the United States.
-
United BioSource (UBC) Acquires MarketShare Movers (MSM)
March 9, 2022
Healthcare Services
United BioSource LLC (UBC) has acquired MarketShare Movers (MSM), a data-driven prescription drug benefit and patient affordability company. The acquisition expands UBC's patient access and affordability capabilities by adding MSM's co-pay program execution, pharmacy adjudication, and proprietary analytics to UBC's patient access and commercialization services.
-
StemBioSys Acquires Majority Stake in Cartox
January 8, 2020
Biotechnology
San Antonio-based StemBioSys acquired a majority stake in Ann Arbor startup Cartox, obtaining control with plans to purchase the remaining equity subject to milestones. The deal brings Cartox's cardiotoxicity imaging and assay capabilities together with StemBioSys's CELLvo extracellular matrix technology to accelerate commercial development of pre-clinical cardiac safety and efficacy screening solutions.
-
Abenex Acquires Cisbio Bioassays from Argos Soditic
June 16, 2016
Biotechnology
French private equity firm Abenex has acquired Cisbio Bioassays from seller Argos Soditic. Abenex will partner with the biotech to support its organic and external growth strategy across pharmaceutical research and in vitro diagnostics; Cisbio has ~210 employees and generates over 85% of revenue outside France.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.